英文别名(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine,dihydrochloride; cis-1-Benzyl-N-methyl-4-methylpiperidin-3-amine dihydrochloride; cis-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride; Tofacitinib Impurity 02; Tofacitinib Impurity 108 DiHCl; (3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine diHCl; (3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-aminedihydrochloride; (3S,4S)-1-Benzyl-N,4-dimethyl-3-piperidinamine dihydrochloride; (3S,4S)-1-benzyl-N,4-dimethyl-piperidin-3-amine dihydrochloride; 1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride, (3S,4S)-; 1-Benzyl-N-methyl-4-methylpiperidin-3-amine dihydrochloride, cis-; (3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine--hydrogen chloride (1/2); 3-Piperidinamine, N,4-dimethyl-1-(phenylmethyl)-, dihydrochloride, (3R,4R)-rel-; 3-Piperidinamine, N,4-dimethyl-1-(phenylmethyl)-, hydrochloride (1:2), (3R,4R)-rel-; 3-Piperidinamine, N,4-dimethyl-1-(phenylmethyl)-, hydrochloride (1:2), (3S,4S)-; racemic cis-(1-benzyl-4-methyl-piperidine-3-yl)-methylamine bis hydrochloride; (3S,4S)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride (1:2); 3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,hydrochloride(1:2),(3S,4S)-; Tofacitinib-2; Tofacitinib Impurity 18 DiHCl 
